LOC105374341 as a Target for Neurodegenerative Diseases (G105374341)
LOC105374341 as a Target for Neurodegenerative Diseases
LOC105374341 (LOC105374341 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoplasmic proteins, which are involved in various cellular processes in eukaryotic cells. One of the unique features of LOC105374341 is its ability to interact with small molecules, such as drugs, toxins, and other substances that are present in the body. This interactivity makes LOC105374341 an attractive target for drug development, particularly in the context of neurodegenerative diseases.
The LOC105374341 protein is composed of 156 amino acids and has a calculated molecular mass of 19.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is involved in various cellular processes, including cell signaling, metabolism, and stress resistance. One of the most interesting features of LOC105374341 is its ability to interact with small molecules, such as drugs, toxins, and other substances that are present in the body. This interactivity makes LOC105374341 an attractive target for drug development, particularly in the context of neurodegenerative diseases.
In neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, the accumulation of misfolded proteins is thought to play a significant role in the development and progression of the disease. LOC105374341 has been shown to interact with various misfolded proteins, including beta-amyloid, tau, and p53, which are known to contribute to the development and progression of these diseases. In addition, LOC105374341 has also been shown to interact with small molecules that are known to be involved in neurodegenerative diseases, such as neurotoxins and environmental toxins.
The ability of LOC105374341 to interact with small molecules makes it an attractive target for drug development in the context of neurodegenerative diseases. Studies have shown that LOC105374341 can be effectively targeted with small molecules, such as taxanes, which are commonly used in the treatment of cancer. In addition, LOC105374341 has also been shown to be sensitive to inhibitors of protein-protein interactions, such as small molecule inhibitors of tyrosination and phosphorylation. This suggests that LOC105374341 may be an effective target for neurodegenerative diseases that are treated with small molecules.
Another promising aspect of LOC105374341 is its ability to modulate the activity of other proteins. Studies have shown that LOC105374341 can interact with various protein partners, including transcription factors, to enhance their activity. This suggests that LOC105374341 may be a useful target for diseases that are characterized by disruptions in protein function, such as neurodegenerative diseases.
In conclusion, LOC105374341 is an attractive target for drug development in the context of neurodegenerative diseases due to its ability to interact with small molecules and other proteins. The accumulation of misfolded proteins in these diseases is thought to contribute to their development and progression, and the interaction of LOC105374341 with these proteins may be a significant factor in their pathogenesis. Additionally, LOC105374341 has also been shown to modulate the activity of other proteins, which suggests that it may be a useful target for diseases characterized by disruptions in protein function. Further research is needed to fully understand the role of LOC105374341 in neurodegenerative diseases and to develop effective treatments based on this target.
Protein Name: Uncharacterized LOC105374341
The "LOC105374341 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374341 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194
